Ergomed plc Notice of AGM and Annual Report (8038A)
May 26 2023 - 3:38AM
UK Regulatory
TIDMERGO
RNS Number : 8038A
Ergomed plc
26 May 2023
Notice of AGM and Annual Report
Guildford, UK - 26 May 2023 : Ergomed plc (LSE: ERGO) ("Ergomed"
or the "Company"), a company focused on providing specialised
services to the pharmaceutical industry, announces that its Annual
General Meeting ("AGM") will be held at 85 Gresham Street, London,
EC2V 7NQ at 9:30 a.m. on Thursday, 22 June 2023.
Ergomed's Annual Report and Accounts for the year ended 31
December 2022, Notice of AGM and Form of Proxy will be available on
the Company's website at www.ergomedplc.com and are being mailed to
its shareholders today.
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402
975
Miroslav Reljanović (Executive
Chairman)
Jonathan Curtain (Chief Financial
Officer)
Keith Byrne (Senior Vice President,
Capital Markets and Strategy)
Numis Securities Limited (Nominated Tel: +44 (0) 20 7260
Adviser and Joint Broker) 1000
Freddie Barnfield / Euan Brown / Jack
McLaren
Peel Hunt Securities Limited (Joint
Broker) Tel: +44 (0) 20 7418
James Steel / Dr Christopher Golden 8900
Consilium Strategic Communications Tel: +44 (0) 20 3709
-for UK enquiries 5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand, a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO) and mission-critical regulatory compliance and consulting
services under the ADAMAS brand. For further information, visit:
http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOANKABNOBKKAPB
(END) Dow Jones Newswires
May 26, 2023 03:38 ET (07:38 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024